nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—CYP1B1—Mitoxantrone—multiple sclerosis	0.0665	0.117	CbGbCtD
Docetaxel—ABCC10—Methotrexate—multiple sclerosis	0.051	0.0895	CbGbCtD
Docetaxel—ABCC1—Mitoxantrone—multiple sclerosis	0.0473	0.083	CbGbCtD
Docetaxel—ABCG2—Cladribine—multiple sclerosis	0.0433	0.0761	CbGbCtD
Docetaxel—CYP1B1—Dexamethasone—multiple sclerosis	0.0345	0.0605	CbGbCtD
Docetaxel—ABCG2—Mitoxantrone—multiple sclerosis	0.0316	0.0555	CbGbCtD
Docetaxel—SLCO1B3—Methotrexate—multiple sclerosis	0.0285	0.05	CbGbCtD
Docetaxel—SLC22A7—Methotrexate—multiple sclerosis	0.0251	0.044	CbGbCtD
Docetaxel—ABCC1—Methotrexate—multiple sclerosis	0.0197	0.0346	CbGbCtD
Docetaxel—ABCC2—Dexamethasone—multiple sclerosis	0.0181	0.0318	CbGbCtD
Docetaxel—ABCG2—Dexamethasone—multiple sclerosis	0.0164	0.0288	CbGbCtD
Docetaxel—ABCB1—Methylprednisolone—multiple sclerosis	0.0156	0.0274	CbGbCtD
Docetaxel—ABCC2—Methotrexate—multiple sclerosis	0.0146	0.0256	CbGbCtD
Docetaxel—CYP3A4—Fingolimod—multiple sclerosis	0.0145	0.0255	CbGbCtD
Docetaxel—ABCG2—Methotrexate—multiple sclerosis	0.0132	0.0231	CbGbCtD
Docetaxel—CYP3A7—Dexamethasone—multiple sclerosis	0.0121	0.0213	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0121	0.0213	CbGbCtD
Docetaxel—ABCB1—Mitoxantrone—multiple sclerosis	0.0114	0.02	CbGbCtD
Docetaxel—ABCB1—Betamethasone—multiple sclerosis	0.0102	0.0178	CbGbCtD
Docetaxel—ABCB1—Prednisolone—multiple sclerosis	0.01	0.0176	CbGbCtD
Docetaxel—ABCB1—Prednisone—multiple sclerosis	0.00947	0.0166	CbGbCtD
Docetaxel—CYP3A4—Methylprednisolone—multiple sclerosis	0.00937	0.0164	CbGbCtD
Docetaxel—CYP3A5—Dexamethasone—multiple sclerosis	0.00908	0.0159	CbGbCtD
Docetaxel—CYP3A4—Triamcinolone—multiple sclerosis	0.0071	0.0125	CbGbCtD
Docetaxel—CYP3A4—Mitoxantrone—multiple sclerosis	0.00683	0.012	CbGbCtD
Docetaxel—CYP3A4—Betamethasone—multiple sclerosis	0.00609	0.0107	CbGbCtD
Docetaxel—CYP3A4—Prednisolone—multiple sclerosis	0.00601	0.0105	CbGbCtD
Docetaxel—ABCB1—Dexamethasone—multiple sclerosis	0.00591	0.0104	CbGbCtD
Docetaxel—CYP3A4—Prednisone—multiple sclerosis	0.00567	0.00996	CbGbCtD
Docetaxel—ABCB1—Methotrexate—multiple sclerosis	0.00475	0.00834	CbGbCtD
Docetaxel—GHRHR—brainstem—multiple sclerosis	0.00428	0.0492	CbGeAlD
Docetaxel—CYP3A4—Dexamethasone—multiple sclerosis	0.00354	0.00622	CbGbCtD
Docetaxel—MAP2—nerve—multiple sclerosis	0.00308	0.0354	CbGeAlD
Docetaxel—GHRHR—nervous system—multiple sclerosis	0.00224	0.0258	CbGeAlD
Docetaxel—GHRHR—central nervous system—multiple sclerosis	0.00216	0.0248	CbGeAlD
Docetaxel—GHRHR—cerebellum—multiple sclerosis	0.00211	0.0243	CbGeAlD
Docetaxel—MAPT—retina—multiple sclerosis	0.00206	0.0237	CbGeAlD
Docetaxel—KIF11—Clofarabine—Cladribine—multiple sclerosis	0.00197	0.647	CbGdCrCtD
Docetaxel—GHRHR—brain—multiple sclerosis	0.00171	0.0197	CbGeAlD
Docetaxel—MAP4—brainstem—multiple sclerosis	0.00168	0.0193	CbGeAlD
Docetaxel—MAP4—retina—multiple sclerosis	0.00162	0.0186	CbGeAlD
Docetaxel—MAPT—medulla oblongata—multiple sclerosis	0.00149	0.0171	CbGeAlD
Docetaxel—KIF11—brain—multiple sclerosis	0.00146	0.0168	CbGeAlD
Docetaxel—MAPT—midbrain—multiple sclerosis	0.00136	0.0156	CbGeAlD
Docetaxel—MAPT—spinal cord—multiple sclerosis	0.00133	0.0153	CbGeAlD
Docetaxel—MAP2—brainstem—multiple sclerosis	0.00132	0.0152	CbGeAlD
Docetaxel—TUBB8—nervous system—multiple sclerosis	0.00129	0.0148	CbGeAlD
Docetaxel—MAP2—retina—multiple sclerosis	0.00127	0.0147	CbGeAlD
Docetaxel—TUBB8—central nervous system—multiple sclerosis	0.00124	0.0143	CbGeAlD
Docetaxel—MAP4—medulla oblongata—multiple sclerosis	0.00117	0.0134	CbGeAlD
Docetaxel—MAP4—midbrain—multiple sclerosis	0.00107	0.0123	CbGeAlD
Docetaxel—MAPT—cerebellum—multiple sclerosis	0.00105	0.0121	CbGeAlD
Docetaxel—MAP4—spinal cord—multiple sclerosis	0.00104	0.012	CbGeAlD
Docetaxel—TUBB4A—brainstem—multiple sclerosis	0.00102	0.0117	CbGeAlD
Docetaxel—TUBB4A—retina—multiple sclerosis	0.000985	0.0113	CbGeAlD
Docetaxel—TUBB8—brain—multiple sclerosis	0.000984	0.0113	CbGeAlD
Docetaxel—TUBB2B—retina—multiple sclerosis	0.000952	0.0109	CbGeAlD
Docetaxel—MAP2—medulla oblongata—multiple sclerosis	0.000921	0.0106	CbGeAlD
Docetaxel—MAP4—nervous system—multiple sclerosis	0.000879	0.0101	CbGeAlD
Docetaxel—TUBB3—nervous system—multiple sclerosis	0.000879	0.0101	CbGeAlD
Docetaxel—TUBB1—nervous system—multiple sclerosis	0.000859	0.00988	CbGeAlD
Docetaxel—MAPT—brain—multiple sclerosis	0.000854	0.00982	CbGeAlD
Docetaxel—TUBB3—central nervous system—multiple sclerosis	0.000846	0.00973	CbGeAlD
Docetaxel—MAP4—central nervous system—multiple sclerosis	0.000846	0.00973	CbGeAlD
Docetaxel—MAP2—midbrain—multiple sclerosis	0.000842	0.00968	CbGeAlD
Docetaxel—TUBB1—central nervous system—multiple sclerosis	0.000827	0.00951	CbGeAlD
Docetaxel—MAP4—cerebellum—multiple sclerosis	0.000827	0.00951	CbGeAlD
Docetaxel—TUBB3—cerebellum—multiple sclerosis	0.000827	0.00951	CbGeAlD
Docetaxel—MAP2—spinal cord—multiple sclerosis	0.000821	0.00944	CbGeAlD
Docetaxel—BCL2—nervous system—multiple sclerosis	0.000799	0.00919	CbGeAlD
Docetaxel—BCL2—central nervous system—multiple sclerosis	0.000769	0.00884	CbGeAlD
Docetaxel—TUBB4B—retina—multiple sclerosis	0.000768	0.00883	CbGeAlD
Docetaxel—TUBB—Azacitidine—Cladribine—multiple sclerosis	0.00076	0.25	CbGdCrCtD
Docetaxel—EGFR—cerebellum—multiple sclerosis	0.000743	0.00854	CbGeAlD
Docetaxel—TUBB4A—medulla oblongata—multiple sclerosis	0.000712	0.00818	CbGeAlD
Docetaxel—MAP2—nervous system—multiple sclerosis	0.000692	0.00796	CbGeAlD
Docetaxel—TUBB2B—medulla oblongata—multiple sclerosis	0.000688	0.00791	CbGeAlD
Docetaxel—TUBB3—brain—multiple sclerosis	0.000672	0.00772	CbGeAlD
Docetaxel—MAP4—brain—multiple sclerosis	0.000672	0.00772	CbGeAlD
Docetaxel—MAP2—central nervous system—multiple sclerosis	0.000666	0.00766	CbGeAlD
Docetaxel—TUBB1—brain—multiple sclerosis	0.000657	0.00755	CbGeAlD
Docetaxel—MAP2—cerebellum—multiple sclerosis	0.000651	0.00749	CbGeAlD
Docetaxel—TUBB—medulla oblongata—multiple sclerosis	0.000651	0.00748	CbGeAlD
Docetaxel—TUBB4A—midbrain—multiple sclerosis	0.00065	0.00748	CbGeAlD
Docetaxel—TUBB2A—medulla oblongata—multiple sclerosis	0.000647	0.00745	CbGeAlD
Docetaxel—TUBB6—medulla oblongata—multiple sclerosis	0.000639	0.00734	CbGeAlD
Docetaxel—TUBB4A—spinal cord—multiple sclerosis	0.000635	0.0073	CbGeAlD
Docetaxel—TUBB2B—midbrain—multiple sclerosis	0.000629	0.00723	CbGeAlD
Docetaxel—TUBB2B—spinal cord—multiple sclerosis	0.000613	0.00705	CbGeAlD
Docetaxel—BCL2—brain—multiple sclerosis	0.000611	0.00702	CbGeAlD
Docetaxel—EGFR—brain—multiple sclerosis	0.000603	0.00694	CbGeAlD
Docetaxel—TUBB—midbrain—multiple sclerosis	0.000595	0.00684	CbGeAlD
Docetaxel—TUBB2A—midbrain—multiple sclerosis	0.000592	0.0068	CbGeAlD
Docetaxel—TUBB6—midbrain—multiple sclerosis	0.000584	0.00671	CbGeAlD
Docetaxel—TUBB—spinal cord—multiple sclerosis	0.00058	0.00667	CbGeAlD
Docetaxel—TUBB2A—spinal cord—multiple sclerosis	0.000577	0.00664	CbGeAlD
Docetaxel—TUBB6—spinal cord—multiple sclerosis	0.000569	0.00655	CbGeAlD
Docetaxel—ABCC10—medulla oblongata—multiple sclerosis	0.000559	0.00643	CbGeAlD
Docetaxel—TUBB4B—medulla oblongata—multiple sclerosis	0.000555	0.00638	CbGeAlD
Docetaxel—TUBB4A—nervous system—multiple sclerosis	0.000535	0.00615	CbGeAlD
Docetaxel—MAP2—brain—multiple sclerosis	0.000529	0.00608	CbGeAlD
Docetaxel—TUBB2B—nervous system—multiple sclerosis	0.000517	0.00594	CbGeAlD
Docetaxel—TUBB4A—central nervous system—multiple sclerosis	0.000515	0.00592	CbGeAlD
Docetaxel—ABCC10—midbrain—multiple sclerosis	0.000511	0.00588	CbGeAlD
Docetaxel—TUBB4B—midbrain—multiple sclerosis	0.000507	0.00583	CbGeAlD
Docetaxel—TUBB4A—cerebellum—multiple sclerosis	0.000503	0.00579	CbGeAlD
Docetaxel—ABCC10—spinal cord—multiple sclerosis	0.000499	0.00573	CbGeAlD
Docetaxel—TUBB2B—central nervous system—multiple sclerosis	0.000498	0.00572	CbGeAlD
Docetaxel—TUBB4B—spinal cord—multiple sclerosis	0.000495	0.00569	CbGeAlD
Docetaxel—TUBB2A—nervous system—multiple sclerosis	0.000486	0.00559	CbGeAlD
Docetaxel—TUBB2B—cerebellum—multiple sclerosis	0.000486	0.00559	CbGeAlD
Docetaxel—TUBB6—nervous system—multiple sclerosis	0.00048	0.00552	CbGeAlD
Docetaxel—TUBB2A—central nervous system—multiple sclerosis	0.000468	0.00539	CbGeAlD
Docetaxel—TUBB6—central nervous system—multiple sclerosis	0.000462	0.00531	CbGeAlD
Docetaxel—TUBB—cerebellum—multiple sclerosis	0.00046	0.00529	CbGeAlD
Docetaxel—TUBB2A—cerebellum—multiple sclerosis	0.000458	0.00526	CbGeAlD
Docetaxel—SLC22A7—brain—multiple sclerosis	0.000457	0.00526	CbGeAlD
Docetaxel—TUBB6—cerebellum—multiple sclerosis	0.000452	0.00519	CbGeAlD
Docetaxel—TUBB4B—nervous system—multiple sclerosis	0.000417	0.0048	CbGeAlD
Docetaxel—TUBB4A—brain—multiple sclerosis	0.000409	0.0047	CbGeAlD
Docetaxel—TUBB4B—central nervous system—multiple sclerosis	0.000402	0.00462	CbGeAlD
Docetaxel—ABCC10—cerebellum—multiple sclerosis	0.000395	0.00455	CbGeAlD
Docetaxel—TUBB2B—brain—multiple sclerosis	0.000395	0.00454	CbGeAlD
Docetaxel—TUBB4B—cerebellum—multiple sclerosis	0.000392	0.00451	CbGeAlD
Docetaxel—TUBB—brain—multiple sclerosis	0.000374	0.0043	CbGeAlD
Docetaxel—TUBB2A—brain—multiple sclerosis	0.000372	0.00428	CbGeAlD
Docetaxel—TUBB6—brain—multiple sclerosis	0.000367	0.00422	CbGeAlD
Docetaxel—CYP1B1—nervous system—multiple sclerosis	0.00033	0.0038	CbGeAlD
Docetaxel—ABCG2—medulla oblongata—multiple sclerosis	0.000327	0.00376	CbGeAlD
Docetaxel—ABCC10—brain—multiple sclerosis	0.000321	0.00369	CbGeAlD
Docetaxel—TUBB4B—brain—multiple sclerosis	0.000319	0.00367	CbGeAlD
Docetaxel—CYP1B1—central nervous system—multiple sclerosis	0.000318	0.00366	CbGeAlD
Docetaxel—TUBB6—Azacitidine—Cladribine—multiple sclerosis	0.000314	0.103	CbGdCrCtD
Docetaxel—CYP1B1—cerebellum—multiple sclerosis	0.000311	0.00357	CbGeAlD
Docetaxel—ABCG2—midbrain—multiple sclerosis	0.000299	0.00344	CbGeAlD
Docetaxel—ABCG2—spinal cord—multiple sclerosis	0.000292	0.00336	CbGeAlD
Docetaxel—ABCC1—cerebellum—multiple sclerosis	0.00028	0.00322	CbGeAlD
Docetaxel—CYP1B1—brain—multiple sclerosis	0.000253	0.0029	CbGeAlD
Docetaxel—ABCG2—cerebellum—multiple sclerosis	0.000231	0.00266	CbGeAlD
Docetaxel—ABCC1—brain—multiple sclerosis	0.000227	0.00261	CbGeAlD
Docetaxel—ABCB1—retina—multiple sclerosis	0.000223	0.00257	CbGeAlD
Docetaxel—ABCG2—brain—multiple sclerosis	0.000188	0.00216	CbGeAlD
Docetaxel—CYP3A4—nervous system—multiple sclerosis	0.000171	0.00197	CbGeAlD
Docetaxel—CYP3A4—central nervous system—multiple sclerosis	0.000165	0.0019	CbGeAlD
Docetaxel—ABCB1—medulla oblongata—multiple sclerosis	0.000161	0.00186	CbGeAlD
Docetaxel—ABCB1—midbrain—multiple sclerosis	0.000148	0.0017	CbGeAlD
Docetaxel—ABCB1—spinal cord—multiple sclerosis	0.000144	0.00166	CbGeAlD
Docetaxel—ABCB1—nervous system—multiple sclerosis	0.000121	0.00139	CbGeAlD
Docetaxel—ABCB1—central nervous system—multiple sclerosis	0.000117	0.00134	CbGeAlD
Docetaxel—ABCB1—cerebellum—multiple sclerosis	0.000114	0.00131	CbGeAlD
Docetaxel—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000101	0.000489	CcSEcCtD
Docetaxel—Dry mouth—Triamcinolone—multiple sclerosis	0.0001	0.000486	CcSEcCtD
Docetaxel—Renal failure—Methotrexate—multiple sclerosis	9.98e-05	0.000485	CcSEcCtD
Docetaxel—Stomatitis—Methotrexate—multiple sclerosis	9.9e-05	0.000481	CcSEcCtD
Docetaxel—Angiopathy—Prednisone—multiple sclerosis	9.9e-05	0.000481	CcSEcCtD
Docetaxel—Conjunctivitis—Methotrexate—multiple sclerosis	9.87e-05	0.000479	CcSEcCtD
Docetaxel—Confusional state—Methylprednisolone—multiple sclerosis	9.87e-05	0.000479	CcSEcCtD
Docetaxel—Immune system disorder—Prednisone—multiple sclerosis	9.85e-05	0.000479	CcSEcCtD
Docetaxel—Oedema—Triamcinolone—multiple sclerosis	9.81e-05	0.000476	CcSEcCtD
Docetaxel—Anaphylactic shock—Triamcinolone—multiple sclerosis	9.81e-05	0.000476	CcSEcCtD
Docetaxel—Anaphylactic shock—Methylprednisolone—multiple sclerosis	9.79e-05	0.000475	CcSEcCtD
Docetaxel—Syncope—Betamethasone—multiple sclerosis	9.78e-05	0.000475	CcSEcCtD
Docetaxel—Syncope—Dexamethasone—multiple sclerosis	9.78e-05	0.000475	CcSEcCtD
Docetaxel—Arrhythmia—Prednisone—multiple sclerosis	9.75e-05	0.000473	CcSEcCtD
Docetaxel—Infection—Triamcinolone—multiple sclerosis	9.74e-05	0.000473	CcSEcCtD
Docetaxel—Infection—Methylprednisolone—multiple sclerosis	9.72e-05	0.000472	CcSEcCtD
Docetaxel—Shock—Triamcinolone—multiple sclerosis	9.65e-05	0.000469	CcSEcCtD
Docetaxel—Insomnia—Prednisolone—multiple sclerosis	9.65e-05	0.000469	CcSEcCtD
Docetaxel—Alopecia—Prednisone—multiple sclerosis	9.64e-05	0.000468	CcSEcCtD
Docetaxel—Shock—Methylprednisolone—multiple sclerosis	9.63e-05	0.000468	CcSEcCtD
Docetaxel—Hepatobiliary disease—Methotrexate—multiple sclerosis	9.6e-05	0.000467	CcSEcCtD
Docetaxel—Nervous system disorder—Methylprednisolone—multiple sclerosis	9.6e-05	0.000466	CcSEcCtD
Docetaxel—Loss of consciousness—Betamethasone—multiple sclerosis	9.58e-05	0.000466	CcSEcCtD
Docetaxel—Loss of consciousness—Dexamethasone—multiple sclerosis	9.58e-05	0.000466	CcSEcCtD
Docetaxel—Epistaxis—Methotrexate—multiple sclerosis	9.58e-05	0.000465	CcSEcCtD
Docetaxel—Hypersensitivity—Mitoxantrone—multiple sclerosis	9.58e-05	0.000465	CcSEcCtD
Docetaxel—Paraesthesia—Prednisolone—multiple sclerosis	9.58e-05	0.000465	CcSEcCtD
Docetaxel—Tachycardia—Triamcinolone—multiple sclerosis	9.57e-05	0.000465	CcSEcCtD
Docetaxel—Mental disorder—Prednisone—multiple sclerosis	9.56e-05	0.000464	CcSEcCtD
Docetaxel—Nausea—Azathioprine—multiple sclerosis	9.55e-05	0.000464	CcSEcCtD
Docetaxel—Tachycardia—Methylprednisolone—multiple sclerosis	9.55e-05	0.000464	CcSEcCtD
Docetaxel—Skin disorder—Methylprednisolone—multiple sclerosis	9.51e-05	0.000462	CcSEcCtD
Docetaxel—Erythema—Prednisone—multiple sclerosis	9.5e-05	0.000461	CcSEcCtD
Docetaxel—Malnutrition—Prednisone—multiple sclerosis	9.5e-05	0.000461	CcSEcCtD
Docetaxel—Agranulocytosis—Methotrexate—multiple sclerosis	9.48e-05	0.00046	CcSEcCtD
Docetaxel—Convulsion—Dexamethasone—multiple sclerosis	9.45e-05	0.000459	CcSEcCtD
Docetaxel—Convulsion—Betamethasone—multiple sclerosis	9.45e-05	0.000459	CcSEcCtD
Docetaxel—Hypertension—Betamethasone—multiple sclerosis	9.41e-05	0.000457	CcSEcCtD
Docetaxel—Hypertension—Dexamethasone—multiple sclerosis	9.41e-05	0.000457	CcSEcCtD
Docetaxel—Asthenia—Mitoxantrone—multiple sclerosis	9.33e-05	0.000453	CcSEcCtD
Docetaxel—Myalgia—Betamethasone—multiple sclerosis	9.28e-05	0.000451	CcSEcCtD
Docetaxel—Myalgia—Dexamethasone—multiple sclerosis	9.28e-05	0.000451	CcSEcCtD
Docetaxel—ABCB1—brain—multiple sclerosis	9.27e-05	0.00107	CbGeAlD
Docetaxel—Haemoglobin—Methotrexate—multiple sclerosis	9.16e-05	0.000445	CcSEcCtD
Docetaxel—Hypotension—Methylprednisolone—multiple sclerosis	9.14e-05	0.000444	CcSEcCtD
Docetaxel—Pain—Prednisolone—multiple sclerosis	9.12e-05	0.000443	CcSEcCtD
Docetaxel—Haemorrhage—Methotrexate—multiple sclerosis	9.12e-05	0.000443	CcSEcCtD
Docetaxel—Hepatitis—Methotrexate—multiple sclerosis	9.12e-05	0.000443	CcSEcCtD
Docetaxel—Pharyngitis—Methotrexate—multiple sclerosis	9.05e-05	0.000439	CcSEcCtD
Docetaxel—Urinary tract disorder—Methotrexate—multiple sclerosis	9e-05	0.000437	CcSEcCtD
Docetaxel—Urethral disorder—Methotrexate—multiple sclerosis	8.94e-05	0.000434	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.94e-05	0.000434	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8.92e-05	0.000433	CcSEcCtD
Docetaxel—Oedema—Betamethasone—multiple sclerosis	8.9e-05	0.000432	CcSEcCtD
Docetaxel—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.9e-05	0.000432	CcSEcCtD
Docetaxel—Oedema—Dexamethasone—multiple sclerosis	8.9e-05	0.000432	CcSEcCtD
Docetaxel—Anaphylactic shock—Betamethasone—multiple sclerosis	8.9e-05	0.000432	CcSEcCtD
Docetaxel—Diarrhoea—Mitoxantrone—multiple sclerosis	8.89e-05	0.000432	CcSEcCtD
Docetaxel—Insomnia—Triamcinolone—multiple sclerosis	8.87e-05	0.000431	CcSEcCtD
Docetaxel—Insomnia—Methylprednisolone—multiple sclerosis	8.85e-05	0.00043	CcSEcCtD
Docetaxel—Infection—Betamethasone—multiple sclerosis	8.84e-05	0.000429	CcSEcCtD
Docetaxel—Infection—Dexamethasone—multiple sclerosis	8.84e-05	0.000429	CcSEcCtD
Docetaxel—Paraesthesia—Triamcinolone—multiple sclerosis	8.81e-05	0.000428	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisolone—multiple sclerosis	8.79e-05	0.000427	CcSEcCtD
Docetaxel—Paraesthesia—Methylprednisolone—multiple sclerosis	8.79e-05	0.000427	CcSEcCtD
Docetaxel—Visual impairment—Methotrexate—multiple sclerosis	8.79e-05	0.000427	CcSEcCtD
Docetaxel—Anaemia—Prednisone—multiple sclerosis	8.78e-05	0.000426	CcSEcCtD
Docetaxel—Shock—Dexamethasone—multiple sclerosis	8.76e-05	0.000425	CcSEcCtD
Docetaxel—Shock—Betamethasone—multiple sclerosis	8.76e-05	0.000425	CcSEcCtD
Docetaxel—Dyspnoea—Triamcinolone—multiple sclerosis	8.74e-05	0.000425	CcSEcCtD
Docetaxel—Nervous system disorder—Dexamethasone—multiple sclerosis	8.73e-05	0.000424	CcSEcCtD
Docetaxel—Nervous system disorder—Betamethasone—multiple sclerosis	8.73e-05	0.000424	CcSEcCtD
Docetaxel—Thrombocytopenia—Betamethasone—multiple sclerosis	8.71e-05	0.000423	CcSEcCtD
Docetaxel—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.71e-05	0.000423	CcSEcCtD
Docetaxel—Tachycardia—Dexamethasone—multiple sclerosis	8.69e-05	0.000422	CcSEcCtD
Docetaxel—Tachycardia—Betamethasone—multiple sclerosis	8.69e-05	0.000422	CcSEcCtD
Docetaxel—Dyspepsia—Triamcinolone—multiple sclerosis	8.63e-05	0.000419	CcSEcCtD
Docetaxel—Erythema multiforme—Methotrexate—multiple sclerosis	8.62e-05	0.000419	CcSEcCtD
Docetaxel—Dyspepsia—Methylprednisolone—multiple sclerosis	8.61e-05	0.000418	CcSEcCtD
Docetaxel—Eye disorder—Methotrexate—multiple sclerosis	8.52e-05	0.000414	CcSEcCtD
Docetaxel—Syncope—Prednisone—multiple sclerosis	8.52e-05	0.000414	CcSEcCtD
Docetaxel—Anorexia—Dexamethasone—multiple sclerosis	8.48e-05	0.000412	CcSEcCtD
Docetaxel—Anorexia—Betamethasone—multiple sclerosis	8.48e-05	0.000412	CcSEcCtD
Docetaxel—Cardiac disorder—Methotrexate—multiple sclerosis	8.46e-05	0.000411	CcSEcCtD
Docetaxel—Fatigue—Triamcinolone—multiple sclerosis	8.46e-05	0.000411	CcSEcCtD
Docetaxel—Fatigue—Methylprednisolone—multiple sclerosis	8.44e-05	0.00041	CcSEcCtD
Docetaxel—Pain—Triamcinolone—multiple sclerosis	8.39e-05	0.000407	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—multiple sclerosis	8.35e-05	0.000405	CcSEcCtD
Docetaxel—Hypotension—Betamethasone—multiple sclerosis	8.32e-05	0.000404	CcSEcCtD
Docetaxel—Hypotension—Dexamethasone—multiple sclerosis	8.32e-05	0.000404	CcSEcCtD
Docetaxel—Angiopathy—Methotrexate—multiple sclerosis	8.27e-05	0.000402	CcSEcCtD
Docetaxel—Vomiting—Mitoxantrone—multiple sclerosis	8.27e-05	0.000401	CcSEcCtD
Docetaxel—Immune system disorder—Methotrexate—multiple sclerosis	8.23e-05	0.0004	CcSEcCtD
Docetaxel—Convulsion—Prednisone—multiple sclerosis	8.23e-05	0.0004	CcSEcCtD
Docetaxel—Mediastinal disorder—Methotrexate—multiple sclerosis	8.22e-05	0.000399	CcSEcCtD
Docetaxel—Hypertension—Prednisone—multiple sclerosis	8.2e-05	0.000398	CcSEcCtD
Docetaxel—Rash—Mitoxantrone—multiple sclerosis	8.2e-05	0.000398	CcSEcCtD
Docetaxel—Dermatitis—Mitoxantrone—multiple sclerosis	8.19e-05	0.000398	CcSEcCtD
Docetaxel—Chills—Methotrexate—multiple sclerosis	8.18e-05	0.000397	CcSEcCtD
Docetaxel—Headache—Mitoxantrone—multiple sclerosis	8.14e-05	0.000396	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	8.11e-05	0.000394	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	8.11e-05	0.000394	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—multiple sclerosis	8.08e-05	0.000393	CcSEcCtD
Docetaxel—Myalgia—Prednisone—multiple sclerosis	8.08e-05	0.000393	CcSEcCtD
Docetaxel—Feeling abnormal—Triamcinolone—multiple sclerosis	8.08e-05	0.000393	CcSEcCtD
Docetaxel—Feeling abnormal—Methylprednisolone—multiple sclerosis	8.06e-05	0.000392	CcSEcCtD
Docetaxel—Alopecia—Methotrexate—multiple sclerosis	8.06e-05	0.000391	CcSEcCtD
Docetaxel—Insomnia—Betamethasone—multiple sclerosis	8.05e-05	0.000391	CcSEcCtD
Docetaxel—Insomnia—Dexamethasone—multiple sclerosis	8.05e-05	0.000391	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	8.03e-05	0.00039	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	8e-05	0.000389	CcSEcCtD
Docetaxel—Paraesthesia—Dexamethasone—multiple sclerosis	7.99e-05	0.000388	CcSEcCtD
Docetaxel—Paraesthesia—Betamethasone—multiple sclerosis	7.99e-05	0.000388	CcSEcCtD
Docetaxel—Mental disorder—Methotrexate—multiple sclerosis	7.99e-05	0.000388	CcSEcCtD
Docetaxel—Erythema—Methotrexate—multiple sclerosis	7.94e-05	0.000385	CcSEcCtD
Docetaxel—Malnutrition—Methotrexate—multiple sclerosis	7.94e-05	0.000385	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisolone—multiple sclerosis	7.86e-05	0.000382	CcSEcCtD
Docetaxel—Dyspepsia—Betamethasone—multiple sclerosis	7.83e-05	0.00038	CcSEcCtD
Docetaxel—Dyspepsia—Dexamethasone—multiple sclerosis	7.83e-05	0.00038	CcSEcCtD
Docetaxel—Dysgeusia—Methotrexate—multiple sclerosis	7.77e-05	0.000377	CcSEcCtD
Docetaxel—Body temperature increased—Triamcinolone—multiple sclerosis	7.75e-05	0.000377	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—multiple sclerosis	7.75e-05	0.000376	CcSEcCtD
Docetaxel—Oedema—Prednisone—multiple sclerosis	7.75e-05	0.000376	CcSEcCtD
Docetaxel—Abdominal pain—Methylprednisolone—multiple sclerosis	7.74e-05	0.000376	CcSEcCtD
Docetaxel—Decreased appetite—Dexamethasone—multiple sclerosis	7.74e-05	0.000376	CcSEcCtD
Docetaxel—Decreased appetite—Betamethasone—multiple sclerosis	7.74e-05	0.000376	CcSEcCtD
Docetaxel—Nausea—Mitoxantrone—multiple sclerosis	7.72e-05	0.000375	CcSEcCtD
Docetaxel—Infection—Prednisone—multiple sclerosis	7.7e-05	0.000374	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	7.68e-05	0.000373	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Betamethasone—multiple sclerosis	7.68e-05	0.000373	CcSEcCtD
Docetaxel—Back pain—Methotrexate—multiple sclerosis	7.68e-05	0.000373	CcSEcCtD
Docetaxel—Fatigue—Dexamethasone—multiple sclerosis	7.67e-05	0.000373	CcSEcCtD
Docetaxel—Fatigue—Betamethasone—multiple sclerosis	7.67e-05	0.000373	CcSEcCtD
Docetaxel—Shock—Prednisone—multiple sclerosis	7.62e-05	0.00037	CcSEcCtD
Docetaxel—Pain—Dexamethasone—multiple sclerosis	7.61e-05	0.00037	CcSEcCtD
Docetaxel—Pain—Betamethasone—multiple sclerosis	7.61e-05	0.00037	CcSEcCtD
Docetaxel—Nervous system disorder—Prednisone—multiple sclerosis	7.6e-05	0.000369	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—multiple sclerosis	7.56e-05	0.000367	CcSEcCtD
Docetaxel—Skin disorder—Prednisone—multiple sclerosis	7.53e-05	0.000366	CcSEcCtD
Docetaxel—Anorexia—Prednisone—multiple sclerosis	7.39e-05	0.000359	CcSEcCtD
Docetaxel—Anaemia—Methotrexate—multiple sclerosis	7.34e-05	0.000356	CcSEcCtD
Docetaxel—Feeling abnormal—Dexamethasone—multiple sclerosis	7.33e-05	0.000356	CcSEcCtD
Docetaxel—Feeling abnormal—Betamethasone—multiple sclerosis	7.33e-05	0.000356	CcSEcCtD
Docetaxel—Gastrointestinal pain—Dexamethasone—multiple sclerosis	7.28e-05	0.000353	CcSEcCtD
Docetaxel—Gastrointestinal pain—Betamethasone—multiple sclerosis	7.28e-05	0.000353	CcSEcCtD
Docetaxel—Hypersensitivity—Triamcinolone—multiple sclerosis	7.23e-05	0.000351	CcSEcCtD
Docetaxel—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.21e-05	0.00035	CcSEcCtD
Docetaxel—Leukopenia—Methotrexate—multiple sclerosis	7.1e-05	0.000345	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.06e-05	0.000343	CcSEcCtD
Docetaxel—Dizziness—Prednisolone—multiple sclerosis	7.05e-05	0.000343	CcSEcCtD
Docetaxel—Asthenia—Triamcinolone—multiple sclerosis	7.04e-05	0.000342	CcSEcCtD
Docetaxel—Body temperature increased—Betamethasone—multiple sclerosis	7.04e-05	0.000342	CcSEcCtD
Docetaxel—Abdominal pain—Dexamethasone—multiple sclerosis	7.04e-05	0.000342	CcSEcCtD
Docetaxel—Body temperature increased—Dexamethasone—multiple sclerosis	7.04e-05	0.000342	CcSEcCtD
Docetaxel—Abdominal pain—Betamethasone—multiple sclerosis	7.04e-05	0.000342	CcSEcCtD
Docetaxel—Asthenia—Methylprednisolone—multiple sclerosis	7.02e-05	0.000341	CcSEcCtD
Docetaxel—Insomnia—Prednisone—multiple sclerosis	7.01e-05	0.00034	CcSEcCtD
Docetaxel—Paraesthesia—Prednisone—multiple sclerosis	6.96e-05	0.000338	CcSEcCtD
Docetaxel—Pruritus—Triamcinolone—multiple sclerosis	6.94e-05	0.000337	CcSEcCtD
Docetaxel—Cough—Methotrexate—multiple sclerosis	6.93e-05	0.000336	CcSEcCtD
Docetaxel—Pruritus—Methylprednisolone—multiple sclerosis	6.92e-05	0.000336	CcSEcCtD
Docetaxel—Convulsion—Methotrexate—multiple sclerosis	6.88e-05	0.000334	CcSEcCtD
Docetaxel—Dyspepsia—Prednisone—multiple sclerosis	6.82e-05	0.000331	CcSEcCtD
Docetaxel—Chest pain—Methotrexate—multiple sclerosis	6.76e-05	0.000328	CcSEcCtD
Docetaxel—Arthralgia—Methotrexate—multiple sclerosis	6.76e-05	0.000328	CcSEcCtD
Docetaxel—Myalgia—Methotrexate—multiple sclerosis	6.76e-05	0.000328	CcSEcCtD
Docetaxel—Decreased appetite—Prednisone—multiple sclerosis	6.74e-05	0.000327	CcSEcCtD
Docetaxel—Rash—Prednisolone—multiple sclerosis	6.72e-05	0.000327	CcSEcCtD
Docetaxel—Dermatitis—Prednisolone—multiple sclerosis	6.72e-05	0.000326	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.71e-05	0.000326	CcSEcCtD
Docetaxel—Diarrhoea—Methylprednisolone—multiple sclerosis	6.7e-05	0.000325	CcSEcCtD
Docetaxel—Fatigue—Prednisone—multiple sclerosis	6.68e-05	0.000325	CcSEcCtD
Docetaxel—Headache—Prednisolone—multiple sclerosis	6.68e-05	0.000325	CcSEcCtD
Docetaxel—Constipation—Prednisone—multiple sclerosis	6.63e-05	0.000322	CcSEcCtD
Docetaxel—Confusional state—Methotrexate—multiple sclerosis	6.53e-05	0.000317	CcSEcCtD
Docetaxel—Dizziness—Triamcinolone—multiple sclerosis	6.49e-05	0.000315	CcSEcCtD
Docetaxel—Anaphylactic shock—Methotrexate—multiple sclerosis	6.48e-05	0.000315	CcSEcCtD
Docetaxel—Dizziness—Methylprednisolone—multiple sclerosis	6.47e-05	0.000314	CcSEcCtD
Docetaxel—Infection—Methotrexate—multiple sclerosis	6.43e-05	0.000313	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisone—multiple sclerosis	6.39e-05	0.00031	CcSEcCtD
Docetaxel—Asthenia—Betamethasone—multiple sclerosis	6.39e-05	0.00031	CcSEcCtD
Docetaxel—Asthenia—Dexamethasone—multiple sclerosis	6.39e-05	0.00031	CcSEcCtD
Docetaxel—Nervous system disorder—Methotrexate—multiple sclerosis	6.35e-05	0.000309	CcSEcCtD
Docetaxel—Thrombocytopenia—Methotrexate—multiple sclerosis	6.34e-05	0.000308	CcSEcCtD
Docetaxel—Gastrointestinal pain—Prednisone—multiple sclerosis	6.34e-05	0.000308	CcSEcCtD
Docetaxel—Nausea—Prednisolone—multiple sclerosis	6.34e-05	0.000308	CcSEcCtD
Docetaxel—Pruritus—Betamethasone—multiple sclerosis	6.3e-05	0.000306	CcSEcCtD
Docetaxel—Pruritus—Dexamethasone—multiple sclerosis	6.3e-05	0.000306	CcSEcCtD
Docetaxel—Skin disorder—Methotrexate—multiple sclerosis	6.29e-05	0.000306	CcSEcCtD
Docetaxel—Vomiting—Triamcinolone—multiple sclerosis	6.24e-05	0.000303	CcSEcCtD
Docetaxel—Vomiting—Methylprednisolone—multiple sclerosis	6.22e-05	0.000302	CcSEcCtD
Docetaxel—Rash—Triamcinolone—multiple sclerosis	6.18e-05	0.0003	CcSEcCtD
Docetaxel—Dermatitis—Triamcinolone—multiple sclerosis	6.18e-05	0.0003	CcSEcCtD
Docetaxel—Anorexia—Methotrexate—multiple sclerosis	6.17e-05	0.0003	CcSEcCtD
Docetaxel—Rash—Methylprednisolone—multiple sclerosis	6.17e-05	0.0003	CcSEcCtD
Docetaxel—Dermatitis—Methylprednisolone—multiple sclerosis	6.16e-05	0.000299	CcSEcCtD
Docetaxel—Headache—Triamcinolone—multiple sclerosis	6.14e-05	0.000298	CcSEcCtD
Docetaxel—Headache—Methylprednisolone—multiple sclerosis	6.13e-05	0.000298	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—multiple sclerosis	6.13e-05	0.000298	CcSEcCtD
Docetaxel—Abdominal pain—Prednisone—multiple sclerosis	6.13e-05	0.000298	CcSEcCtD
Docetaxel—Diarrhoea—Dexamethasone—multiple sclerosis	6.09e-05	0.000296	CcSEcCtD
Docetaxel—Diarrhoea—Betamethasone—multiple sclerosis	6.09e-05	0.000296	CcSEcCtD
Docetaxel—Hypotension—Methotrexate—multiple sclerosis	6.05e-05	0.000294	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.9e-05	0.000287	CcSEcCtD
Docetaxel—Dizziness—Betamethasone—multiple sclerosis	5.88e-05	0.000286	CcSEcCtD
Docetaxel—Dizziness—Dexamethasone—multiple sclerosis	5.88e-05	0.000286	CcSEcCtD
Docetaxel—Insomnia—Methotrexate—multiple sclerosis	5.86e-05	0.000285	CcSEcCtD
Docetaxel—Nausea—Triamcinolone—multiple sclerosis	5.83e-05	0.000283	CcSEcCtD
Docetaxel—Paraesthesia—Methotrexate—multiple sclerosis	5.82e-05	0.000282	CcSEcCtD
Docetaxel—Nausea—Methylprednisolone—multiple sclerosis	5.81e-05	0.000282	CcSEcCtD
Docetaxel—Dyspnoea—Methotrexate—multiple sclerosis	5.77e-05	0.00028	CcSEcCtD
Docetaxel—Somnolence—Methotrexate—multiple sclerosis	5.76e-05	0.00028	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisone—multiple sclerosis	5.71e-05	0.000277	CcSEcCtD
Docetaxel—Dyspepsia—Methotrexate—multiple sclerosis	5.7e-05	0.000277	CcSEcCtD
Docetaxel—Vomiting—Dexamethasone—multiple sclerosis	5.66e-05	0.000275	CcSEcCtD
Docetaxel—Vomiting—Betamethasone—multiple sclerosis	5.66e-05	0.000275	CcSEcCtD
Docetaxel—Decreased appetite—Methotrexate—multiple sclerosis	5.63e-05	0.000273	CcSEcCtD
Docetaxel—Rash—Betamethasone—multiple sclerosis	5.61e-05	0.000273	CcSEcCtD
Docetaxel—Rash—Dexamethasone—multiple sclerosis	5.61e-05	0.000273	CcSEcCtD
Docetaxel—Dermatitis—Betamethasone—multiple sclerosis	5.61e-05	0.000272	CcSEcCtD
Docetaxel—Dermatitis—Dexamethasone—multiple sclerosis	5.61e-05	0.000272	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.59e-05	0.000272	CcSEcCtD
Docetaxel—Fatigue—Methotrexate—multiple sclerosis	5.58e-05	0.000271	CcSEcCtD
Docetaxel—Headache—Betamethasone—multiple sclerosis	5.58e-05	0.000271	CcSEcCtD
Docetaxel—Headache—Dexamethasone—multiple sclerosis	5.58e-05	0.000271	CcSEcCtD
Docetaxel—Asthenia—Prednisone—multiple sclerosis	5.56e-05	0.00027	CcSEcCtD
Docetaxel—Pain—Methotrexate—multiple sclerosis	5.54e-05	0.000269	CcSEcCtD
Docetaxel—Pruritus—Prednisone—multiple sclerosis	5.48e-05	0.000266	CcSEcCtD
Docetaxel—Feeling abnormal—Methotrexate—multiple sclerosis	5.34e-05	0.000259	CcSEcCtD
Docetaxel—Diarrhoea—Prednisone—multiple sclerosis	5.3e-05	0.000258	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.3e-05	0.000257	CcSEcCtD
Docetaxel—Nausea—Betamethasone—multiple sclerosis	5.29e-05	0.000257	CcSEcCtD
Docetaxel—Nausea—Dexamethasone—multiple sclerosis	5.29e-05	0.000257	CcSEcCtD
Docetaxel—Dizziness—Prednisone—multiple sclerosis	5.13e-05	0.000249	CcSEcCtD
Docetaxel—Body temperature increased—Methotrexate—multiple sclerosis	5.12e-05	0.000249	CcSEcCtD
Docetaxel—Abdominal pain—Methotrexate—multiple sclerosis	5.12e-05	0.000249	CcSEcCtD
Docetaxel—Vomiting—Prednisone—multiple sclerosis	4.93e-05	0.000239	CcSEcCtD
Docetaxel—Rash—Prednisone—multiple sclerosis	4.89e-05	0.000237	CcSEcCtD
Docetaxel—Dermatitis—Prednisone—multiple sclerosis	4.88e-05	0.000237	CcSEcCtD
Docetaxel—Headache—Prednisone—multiple sclerosis	4.86e-05	0.000236	CcSEcCtD
Docetaxel—Hypersensitivity—Methotrexate—multiple sclerosis	4.77e-05	0.000232	CcSEcCtD
Docetaxel—Asthenia—Methotrexate—multiple sclerosis	4.65e-05	0.000226	CcSEcCtD
Docetaxel—Nausea—Prednisone—multiple sclerosis	4.6e-05	0.000224	CcSEcCtD
Docetaxel—Pruritus—Methotrexate—multiple sclerosis	4.58e-05	0.000223	CcSEcCtD
Docetaxel—Diarrhoea—Methotrexate—multiple sclerosis	4.43e-05	0.000215	CcSEcCtD
Docetaxel—Dizziness—Methotrexate—multiple sclerosis	4.28e-05	0.000208	CcSEcCtD
Docetaxel—Vomiting—Methotrexate—multiple sclerosis	4.12e-05	0.0002	CcSEcCtD
Docetaxel—Rash—Methotrexate—multiple sclerosis	4.08e-05	0.000198	CcSEcCtD
Docetaxel—Dermatitis—Methotrexate—multiple sclerosis	4.08e-05	0.000198	CcSEcCtD
Docetaxel—Headache—Methotrexate—multiple sclerosis	4.06e-05	0.000197	CcSEcCtD
Docetaxel—Nausea—Methotrexate—multiple sclerosis	3.85e-05	0.000187	CcSEcCtD
Docetaxel—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.97e-05	0.000146	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD86—multiple sclerosis	1.96e-05	0.000146	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.96e-05	0.000146	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.96e-05	0.000146	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—multiple sclerosis	1.95e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—MAPK1—multiple sclerosis	1.95e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.94e-05	0.000144	CbGpPWpGaD
Docetaxel—EGFR—Disease—SLC11A1—multiple sclerosis	1.93e-05	0.000143	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—multiple sclerosis	1.93e-05	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD40LG—multiple sclerosis	1.92e-05	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PTGER4—multiple sclerosis	1.91e-05	0.000142	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HLA-B—multiple sclerosis	1.91e-05	0.000142	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—multiple sclerosis	1.9e-05	0.000142	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—multiple sclerosis	1.9e-05	0.000141	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.9e-05	0.000141	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.9e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RGS1—multiple sclerosis	1.9e-05	0.000141	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.89e-05	0.000141	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MYC—multiple sclerosis	1.88e-05	0.00014	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-B—multiple sclerosis	1.88e-05	0.00014	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.86e-05	0.000139	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TNFAIP3—multiple sclerosis	1.85e-05	0.000138	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—BCHE—multiple sclerosis	1.85e-05	0.000138	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.85e-05	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCR3—multiple sclerosis	1.84e-05	0.000137	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MAPK1—multiple sclerosis	1.84e-05	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-B—multiple sclerosis	1.83e-05	0.000136	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—STAT3—multiple sclerosis	1.83e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	1.83e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—multiple sclerosis	1.82e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GPR65—multiple sclerosis	1.8e-05	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR2—multiple sclerosis	1.79e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—multiple sclerosis	1.79e-05	0.000133	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.77e-05	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	1.76e-05	0.000131	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2RA—multiple sclerosis	1.76e-05	0.000131	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.74e-05	0.00013	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.74e-05	0.000129	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-A—multiple sclerosis	1.74e-05	0.000129	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.74e-05	0.000129	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.71e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—multiple sclerosis	1.71e-05	0.000127	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.71e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—multiple sclerosis	1.7e-05	0.000126	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MYC—multiple sclerosis	1.7e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-A—multiple sclerosis	1.7e-05	0.000126	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFB1—multiple sclerosis	1.69e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—multiple sclerosis	1.69e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—multiple sclerosis	1.68e-05	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD28—multiple sclerosis	1.67e-05	0.000124	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MAPK1—multiple sclerosis	1.66e-05	0.000124	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CNR1—multiple sclerosis	1.65e-05	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR1—multiple sclerosis	1.64e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL13—multiple sclerosis	1.64e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CCR2—multiple sclerosis	1.64e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTPRC—multiple sclerosis	1.64e-05	0.000122	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD28—multiple sclerosis	1.63e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR4—multiple sclerosis	1.62e-05	0.00012	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.59e-05	0.000119	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR4—multiple sclerosis	1.59e-05	0.000118	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DRB1—multiple sclerosis	1.59e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	1.58e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—multiple sclerosis	1.58e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—multiple sclerosis	1.58e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DPB1—multiple sclerosis	1.58e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP9—multiple sclerosis	1.57e-05	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—multiple sclerosis	1.57e-05	0.000117	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.56e-05	0.000116	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—multiple sclerosis	1.56e-05	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—multiple sclerosis	1.56e-05	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DRB1—multiple sclerosis	1.55e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—multiple sclerosis	1.55e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—STAT3—multiple sclerosis	1.55e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD28—multiple sclerosis	1.54e-05	0.000115	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ICAM1—multiple sclerosis	1.53e-05	0.000113	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MAPK1—multiple sclerosis	1.53e-05	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ITGA4—multiple sclerosis	1.52e-05	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40—multiple sclerosis	1.52e-05	0.000113	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.52e-05	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNB1—multiple sclerosis	1.51e-05	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTLA4—multiple sclerosis	1.5e-05	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD80—multiple sclerosis	1.49e-05	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL10—multiple sclerosis	1.49e-05	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ICAM1—multiple sclerosis	1.49e-05	0.000111	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.47e-05	0.000109	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD80—multiple sclerosis	1.47e-05	0.000109	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.44e-05	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD80—multiple sclerosis	1.43e-05	0.000106	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.43e-05	0.000106	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.43e-05	0.000106	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—multiple sclerosis	1.43e-05	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TYK2—multiple sclerosis	1.43e-05	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MAPK1—multiple sclerosis	1.4e-05	0.000104	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	1.4e-05	0.000104	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MAPK1—multiple sclerosis	1.39e-05	0.000104	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.39e-05	0.000103	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.36e-05	0.000101	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MAPK1—multiple sclerosis	1.36e-05	0.000101	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.34e-05	9.97e-05	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.33e-05	9.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—VCAM1—multiple sclerosis	1.33e-05	9.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQA1—multiple sclerosis	1.32e-05	9.83e-05	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.32e-05	9.8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—BCHE—multiple sclerosis	1.31e-05	9.74e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPC5—multiple sclerosis	1.31e-05	9.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL5—multiple sclerosis	1.28e-05	9.54e-05	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—multiple sclerosis	1.28e-05	9.49e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—multiple sclerosis	1.28e-05	9.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MAPK1—multiple sclerosis	1.27e-05	9.45e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—BCHE—multiple sclerosis	1.27e-05	9.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TYK2—multiple sclerosis	1.26e-05	9.36e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SRM—multiple sclerosis	1.25e-05	9.31e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TYK2—multiple sclerosis	1.24e-05	9.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQB1—multiple sclerosis	1.24e-05	9.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD86—multiple sclerosis	1.19e-05	8.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL3—multiple sclerosis	1.17e-05	8.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40LG—multiple sclerosis	1.17e-05	8.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD86—multiple sclerosis	1.17e-05	8.67e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNG—multiple sclerosis	1.16e-05	8.64e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.16e-05	8.63e-05	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.16e-05	8.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR5—multiple sclerosis	1.16e-05	8.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—multiple sclerosis	1.15e-05	8.58e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—BCHE—multiple sclerosis	1.15e-05	8.57e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.14e-05	8.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2RA—multiple sclerosis	1.14e-05	8.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—multiple sclerosis	1.14e-05	8.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTGER4—multiple sclerosis	1.13e-05	8.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP9—multiple sclerosis	1.12e-05	8.35e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—multiple sclerosis	1.12e-05	8.34e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.11e-05	8.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-B—multiple sclerosis	1.11e-05	8.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PGR—multiple sclerosis	1.11e-05	8.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD86—multiple sclerosis	1.1e-05	8.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—multiple sclerosis	1.09e-05	8.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCR3—multiple sclerosis	1.09e-05	8.1e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RRM1—multiple sclerosis	1.08e-05	8.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—multiple sclerosis	1.08e-05	8.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CD28—multiple sclerosis	1.08e-05	8.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR2—multiple sclerosis	1.06e-05	7.88e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—multiple sclerosis	1.04e-05	7.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2RA—multiple sclerosis	1.04e-05	7.74e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—multiple sclerosis	1.04e-05	7.7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CCR5—multiple sclerosis	1.03e-05	7.69e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—multiple sclerosis	1.03e-05	7.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-A—multiple sclerosis	1.03e-05	7.65e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HLA-A—multiple sclerosis	1.01e-05	7.5e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1e-05	7.44e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.99e-06	7.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—multiple sclerosis	9.98e-06	7.42e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.79e-06	7.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CNR1—multiple sclerosis	9.78e-06	7.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—multiple sclerosis	9.77e-06	7.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CCR5—multiple sclerosis	9.75e-06	7.25e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—POMC—multiple sclerosis	9.57e-06	7.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HLA-A—multiple sclerosis	9.5e-06	7.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—multiple sclerosis	9.41e-06	7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APOE—multiple sclerosis	9.41e-06	7e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DRB1—multiple sclerosis	9.4e-06	6.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.32e-06	6.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—multiple sclerosis	9.25e-06	6.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK1—multiple sclerosis	9.07e-06	6.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—POMC—multiple sclerosis	9.03e-06	6.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ICAM1—multiple sclerosis	9.02e-06	6.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOE—multiple sclerosis	8.87e-06	6.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—multiple sclerosis	8.84e-06	6.57e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.82e-06	6.56e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.82e-06	6.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL10—multiple sclerosis	8.8e-06	6.55e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—multiple sclerosis	8.73e-06	6.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD80—multiple sclerosis	8.68e-06	6.46e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—multiple sclerosis	8.68e-06	6.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—multiple sclerosis	8.64e-06	6.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD80—multiple sclerosis	8.51e-06	6.33e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—BCHE—multiple sclerosis	8.26e-06	6.14e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.07e-06	6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TYK2—multiple sclerosis	8.02e-06	5.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD80—multiple sclerosis	8.02e-06	5.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK1—multiple sclerosis	8.01e-06	5.96e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK1—multiple sclerosis	7.89e-06	5.87e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOE—multiple sclerosis	7.88e-06	5.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CD86—multiple sclerosis	7.7e-06	5.72e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOE—multiple sclerosis	7.62e-06	5.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL5—multiple sclerosis	7.58e-06	5.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TYK2—multiple sclerosis	7.33e-06	5.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TYK2—multiple sclerosis	7.18e-06	5.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—multiple sclerosis	7.02e-06	5.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—multiple sclerosis	6.97e-06	5.18e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOE—multiple sclerosis	6.93e-06	5.16e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOE—multiple sclerosis	6.87e-06	5.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—multiple sclerosis	6.87e-06	5.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR5—multiple sclerosis	6.83e-06	5.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—POMC—multiple sclerosis	6.77e-06	5.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TYK2—multiple sclerosis	6.77e-06	5.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2RA—multiple sclerosis	6.73e-06	5e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.68e-06	4.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—multiple sclerosis	6.68e-06	4.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—multiple sclerosis	6.63e-06	4.93e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—multiple sclerosis	6.55e-06	4.87e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—multiple sclerosis	6.49e-06	4.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.27e-06	4.66e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—BCHE—multiple sclerosis	6.23e-06	4.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOE—multiple sclerosis	6.21e-06	4.62e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—multiple sclerosis	6.17e-06	4.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—multiple sclerosis	6.16e-06	4.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—multiple sclerosis	6.12e-06	4.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—multiple sclerosis	6.12e-06	4.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—multiple sclerosis	6.1e-06	4.54e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—multiple sclerosis	6.07e-06	4.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—multiple sclerosis	5.97e-06	4.44e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—multiple sclerosis	5.96e-06	4.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—multiple sclerosis	5.9e-06	4.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CD80—multiple sclerosis	5.61e-06	4.18e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—multiple sclerosis	5.43e-06	4.04e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—multiple sclerosis	5.38e-06	4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—multiple sclerosis	5.34e-06	3.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—multiple sclerosis	5.22e-06	3.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—multiple sclerosis	5.13e-06	3.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK1—multiple sclerosis	5.11e-06	3.8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—multiple sclerosis	5.03e-06	3.74e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOE—multiple sclerosis	4.97e-06	3.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TYK2—multiple sclerosis	4.74e-06	3.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—multiple sclerosis	4.74e-06	3.52e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—multiple sclerosis	4.67e-06	3.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK1—multiple sclerosis	4.67e-06	3.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—multiple sclerosis	4.66e-06	3.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK1—multiple sclerosis	4.57e-06	3.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—multiple sclerosis	4.4e-06	3.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—multiple sclerosis	4.39e-06	3.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK1—multiple sclerosis	4.31e-06	3.2e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—multiple sclerosis	4.27e-06	3.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—multiple sclerosis	3.94e-06	2.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—multiple sclerosis	3.92e-06	2.92e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—multiple sclerosis	3.89e-06	2.89e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.84e-06	2.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOE—multiple sclerosis	3.75e-06	2.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—multiple sclerosis	3.73e-06	2.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—multiple sclerosis	3.59e-06	2.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—multiple sclerosis	3.51e-06	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—multiple sclerosis	3.32e-06	2.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—multiple sclerosis	3.31e-06	2.46e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—multiple sclerosis	3.22e-06	2.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—multiple sclerosis	3.08e-06	2.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—multiple sclerosis	3.08e-06	2.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK1—multiple sclerosis	3.02e-06	2.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—multiple sclerosis	2.94e-06	2.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—multiple sclerosis	2.32e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOE—multiple sclerosis	2.31e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—multiple sclerosis	1.98e-06	1.48e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—multiple sclerosis	1.81e-06	1.35e-05	CbGpPWpGaD
